无针注射器与胰岛素笔治疗糖尿病的meta分析数据集
包含22篇RCT、2580名糖尿病患者的meta分析数据集,比较无针注射器与胰岛素笔的疗效、安全性和患者接受度。

基本信息
资源简介
无针注射器与胰岛素笔治疗糖尿病的meta分析数据集
【一句话概览】
本数据集是 figshare 公开的结构化表格数据集,收录 2 个文件、合计 1.14 MB,主题涵盖 Needle-free injection、diabetes、insulin pen、continuous glucose monitoring、meta-analysis,可用于统计建模、特征工程与队列分析,CC BY 4.0 许可开放获取。
【数据集背景】
本数据集源站标题为《Efficacy, safety, and patient-centered outcomes of needle-free injectors versus insulin pens in diabetes management: a comprehensive meta-analysis》。配套论文《Efficacy, safety, and patient-centered outcomes of needle-free injectors versus insulin pens in diabetes management: a comprehensive meta-analysis》发表于 Drug Delivery(2025),DOI:10.1080/10717544.2025.2597906。项目资助方:This study is supported by the Biopharmaceutical Joint Fund Cultivation Project of the Natural Science Foundation of Hebei Province (H2020206630). This study is also supported by Hebei Medical applicable technology tracking project plan (GZ20260146).。源站首次发布:2025-12-12。
【数据内容】
源站原始描述:To evaluate the comparative effectiveness, safety, and patient acceptance of needle-free injectors and insulin pens through a meta-analysis. A thorough literature search was performed across multiple databases, including CNKI, the Weipu Database, the Wanfang Database, PubMed, Embase, and The Cochrane Library for randomized controlled trials (RCTs) on the use of needle-free injectors and insulin pens in diabetes treatment, with a time frame from database inception until June 2024. Five researcher…
【数据结构与技术规格】
文件数 2 个,合计 1.14 MB。idrd_a_2597906_sm3159.docx:application/vnd.openxmlformats-officedocument.wordprocessingml.document,1.11 MB。idrd_a_2597906_sm3158.xlsx:application/vnd.openxmlformats-officedocument.spreadsheetml.sheet,27.58 KB。数据集 DOI:10.6084/m9.figshare.30870640.v1。
【主题与分类】
源站学科分类:Biochemistry、Medicine、Physiology、Chemical Sciences not elsewhere classified、Science Policy。主题标签:Needle-free injection、diabetes、insulin pen、continuous glucose monitoring、meta-analysis。
【适用方向】
结构化表格数据可直接用于统计建模、特征工程与队列分析。
【获取与许可】
源站页面:https://tandf.figshare.com/articles/dataset/Efficacy_safety_and_patient-centered_outcomes_of_needle-free_injectors_versus_insulin_pens_in_diabetes_management_a_comprehensive_meta-analysis/30870640
使用许可:CC BY 4.0(https://creativecommons.org/licenses/by/4.0/)。
规范引用:Efficacy, safety, and patient-centered outcomes of needle-free injectors versus insulin pens in diabetes management: a comprehensive meta-analysis. Taylor & Francis. Wang, Jing; Chen, Xinhao; Ge, Zhili; Xia, Yingran; Tang, Zixiang; Sun, Zehao; et al
【使用注意】
· 源站最后修改于 2026-01-26,引用时请注意版本时效。
下载信息
注册下载
需要注册 Kaggle 账号并登录后下载,适合需要跟踪下载记录和使用 API 的用户。
暂未开放公开下载
无需注册即可直接获取公开样本或文档,适合快速预览和评估数据集质量。
免登录有偿下载
公开数据集受托下载与技术交付服务。
提供高速下载与技术交付服务(收技术服务费,非数据销售)
暂未开放当前数据集主要来源为 Kaggle 公开托管,完整影像包建议通过原始链接或 Kaggle API 获取。
使用方式
数据集获取(Figshare)
- 源站标题:Efficacy, safety, and patient-centered outcomes of needle-free injectors versus insulin pens in diabetes management: a comprehensive meta-analysis
- DOI:10.6084/m9.figshare.30870640.v1
- 发布日期:2025-12-12
- 文件数:2 个
- 文件总体积:1.14 MB
- 源站页面:https://tandf.figshare.com/articles/dataset/Efficacy_safety_and_patient-centered_outcomes_of_needle-free_injectors_versus_insulin_pens_in_diabetes_management_a_comprehensive_meta-analysis/30870640
命令行下载
curl -L -o "idrd_a_2597906_sm3159.docx" "https://ndownloader.figshare.com/files/60323491"
curl -L -o "idrd_a_2597906_sm3158.xlsx" "https://ndownloader.figshare.com/files/60323494"
文件清单
idrd_a_2597906_sm3159.docx(1.11 MB)idrd_a_2597906_sm3158.xlsx(27.58 KB)
文件总体积 1.14 MB(源站 API 实测)。
数据加载示例(图像类)
from PIL import Image
import glob, os
files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
+ glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
+ glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)
# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path) # 要求 子目录=类别
目录组织与标注格式以源站说明和下载后实际文件为准。
数据说明
To evaluate the comparative effectiveness, safety, and patient acceptance of needle-free injectors and insulin pens through a meta-analysis. A thorough literature search was performed across multiple databases, including CNKI, the Weipu Database, the Wanfang Database, PubMed, Embase, and The Cochrane Library for randomized controlled trials (RCTs) on the use of needle-free injectors and insulin pens in diabetes treatment, with a time frame from database inception until June 2024. Five researchers carefully screened the literature in accordance with the inclusion and exclusion criteria, assessed study quality with validated tools and conducted the meta-analysis using RevMan 5.4. This study included 22 publications encompassing 22 studies, involving a total of 2,580 patients, with 1,290 in the needle-free group and 1,290 in the insulin pen group. The findings suggest that needle-free injectors were superior to insulin pens in improving treatment efficacy, local adverse reactions, and increasing patient acceptability, with statistically significant differences. However, no significant variations were observed in continuous glucose monitoring. Needle-free injectors can improve certain aspects of glycemic control, such as reducing HbA1c, FPG, and 2hPPG; improve local adverse reactions and increase patient acceptability. However, improvements in glycemic variability metrics were not statistically significant, indicating that further research is needed to fully assess their long-term safety and therapeutic effectiveness. In terms of systemic safety, the risk of hypoglycemia in the needle-free group was not significantly different from that in the needle group (P = 0.14). Additionally, our publication bias analysis revealed potential biases in the outcomes related to hypoglycemia and insulin dosage.
许可
CC BY 4.0
引用
学术使用请引用 DOI 10.6084/m9.figshare.30870640.v1(source: https://tandf.figshare.com/articles/dataset/Efficacy_safety_and_patient-centered_outcomes_of_needle-free_injectors_versus_insulin_pens_in_diabetes_management_a_comprehensive_meta-analysis/30870640)。
数据缺失?
依托陕西、四川两大基地,我们与超过十家三甲医院建立直接合作关系,覆盖合规授权、采集治理、专业标注、数据交付的全流程,为AI医疗团队提供即拿即用的高质量临床数据。
⚡️ 需要数据支持或标注服务?立即联系我们获取专业方案。




